Skip to main content

Recombinant Mouse PLTP Protein

R&D Systems, part of Bio-Techne | Catalog # 4918-PL

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
Carrier Free
4918-PL-025/CF

Catalog #
Availability
Size / Price
Qty
With Carrier
4918-PL-025

Key Product Details

Source

NS0

Accession #

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

Mouse myeloma cell line, NS0-derived mouse PLTP protein
Glu18-Ala493, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Glu18

Predicted Molecular Mass

53.5 kDa

SDS-PAGE

70-85 kDa, reducing conditions

Activity

Measured by its ability to inhibit LPS-induced TNF-alpha secretion by RAW 264.7 mouse monocyte/macrophage cells.
3.3 μg/mL of rmPLTP will inhibit 65-95% of the TNF-alpha secretion induced by 0.5 ng/mL of LPS.

Formulation, Preparation and Storage

Carrier Free
What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Carrier: 4918-PL
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution Reconstitute at 250 μg/mL in PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Carrier Free: 4918-PL/CF
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 250 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: PLTP

Phospholipid transfer protein (PLTP; also known as lipid transfer protein II) is an 80 kDa, secreted glycoprotein, that belongs to the BPI/LBP/Plunc superfamily of molecules (1). It is synthesized as a precursor with a 17 amino acid (aa) signal sequence and a 476 aa mature chain. The mature chain contains two BPI/LBP/CETP domains (aa 21 - 239 and 263 - 463) and seven potential sites for N-linked glycosylation. Mature mouse PLTP shares 83% aa sequence identity with mature human PLTP (3). PLTP is expressed by a wide variety of tissues and is secreted by macrophages. Northern blot analysis shows the order of PLTP mRNA expression as follows: lung > adipose tissue, placenta, testis > brain > muscle, heart, liver (2). PLTP is a multifunctional, extracellular lipid transfer protein that plays a major role in lipoprotein metabolism and atherosclerosis (4 - 6). In addition to phospholipids, PLTP transfers several amphipatic compounds, including unesterified cholesterol, lipopolysaccharides, diacylglycerides, and alpha-tocopherol, the main isomer of vitamin E (4). According to several studies, PLTP not only affects plasma lipid and lipoprotein profiles, but also modulates cell physiology (4, 7 - 11). In mice, systemic PLTP deficiency proves to be atheroprotective, whereas PLTP overexpression is proatherogenic (4, 6). However, macrophage PLTP is shown to be atheroprotective (4, 6).

References

  1. Jauhiainen, M. and C. Ehnholm (2005) Methods 36:97.
  2. Jiang, X.-C. and C. Bruce (1995) J. Biol. Chem. 270:17133.
  3. Albers, J.J. et al. (1995) Biochim. Biophys. Acta. 1258:27.
  4. Ogier, N. et al. (2007) Arterioscler. Thromb. Vasc. Biol. 27:2407.
  5. Huuskonen, J. and C. Ehnholm (2000) Curr. Opin. Lipidol. 11:285.
  6. Valenta, D.T. et al. (2008) J. Lipid Res. 49:24.
  7. Jiang, X.-C. et al. (1998) J. Biol. Chem. 273:15714.
  8. Jiang, X.-C. et al. (2005) J. Biol. Chem. 280:18336.
  9. Desrumaux, C. et al. (2005) FASEB J. 19:296.
  10. Drouineaud, V. et al. (2006) FASEB J. 20:794.
  11. Klein, A. et al. (2006) Arterioscler. Thromb. Vasc. Biol. 26:2160.

Long Name

Phospholipid Transfer Protein

Alternate Names

HDLCQ9, Lipid transfer protein II, phospholipid transfer protein

Entrez Gene IDs

5360 (Human); 18830 (Mouse); 296371 (Rat)

Gene Symbol

PLTP

UniProt

Additional PLTP Products

Product Documents for Recombinant Mouse PLTP Protein

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Mouse PLTP Protein

For research use only

Loading...
Loading...
Loading...